EYRC Training Program: interview with Prof. Martin Reincke

EYRC Training Program: interview with Prof. Martin ReinckeOn behalf of the EYRC, Dr Pedro Marques interviewed Professor Martin Reincke during the Annual Congress of the Portuguese Society of Endocrinology in 30 January – 2 February 2025, in Porto, Portugal.Professor Martin Reincke is a well-known Professor of Endocrinology and thecurrent Head of the Department of Medicine IV, University Hospital Munich.Prof Reincke has also been the previous president of the European Society of Endocrinology.His academic interests mainly consist of the pathogenesis and management of endocrine tumors, with a great focus on pituitary and adrenal, and in specific conditions such as Cushing’s syndrome and hyperaldosteronism.In this interview, Prof. Martin Reincke started by highlighting to us the maindevelopments in the diagnostic and management of Cushing’s syndrome. Then, Prof Martin Reincke further shared with us some advice on how to become a world leader academic professor of Neuroendocrinology, and how to find a good balance between professional and personal life. And remember, always ask yourself and your beloved ones if you are doing enough or too much!It was a great privilege to interview Professor Martin Reincke, and we hope that this interview helps you developing your career in the field of Pituitary and Neuroendocrinology! 🔔 Subscribe for more interviews and scientific discussions!📢 Stay Connected with EYRC!Join the ENEA Young Researchers Committee (EYRC) community and stay updated on the latest research, events, and opportunities! Follow us on our official channels:🌐 Website: EYRC Official Page https://enea.org/enea-young-researche...🔗 Social Media:💼 LinkedIn: /enea-young-researcher-committee🐦 X (formerly Twitter): @ENEAssoc📘 Facebook: /eyrc-enea📸 Instagram: /eneayoung💬 Threads: @eneayoung🌎 Bluesky: @eyrc.bsky.social📩 Stay engaged, connect with fellow researchers, and be part of our growing scientific community!

There are no comments yet.

Please log in to write the first comment.